| 395 | 0 | 18 |
| 下载次数 | 被引频次 | 阅读次数 |
猫白血病病毒（Feline leukemia virus, FeLV）是一种常见的对猫具有高度传染性的逆转录病毒，可以通过多种途径传播，在多猫环境中传播尤为迅速。FeLV具有较长的潜伏期，患猫可持续向周围环境排放病毒，目前尚无针对FeLV感染的特效治疗方法。本文就FeLV的结构、分类、分型、受体、致病机制及疫苗等方面的研究进展进行综述，以期为后续开展FeLV相关研究提供参考资料。
Abstract：Feline leukemia virus(FeLV) is a common retrovirus that is highly contagious among cats and can be transmitted through various routes, with transmission being particularly rapid in multi-cat environments. FeLV is characterized by a prolonged incubation period, during which infected cats can continuously shed the virus into their surroundings. Currently, no specific treatment is available for FeLV. This review summarizes recent research on the structure, classification, typing, receptors, pathogenic mechanisms and vaccines of FeLV, aiming to provide a reference for future FeLV-related studies.
[1] Dunham SP, Graham E. Retroviral infections of small animals[J]. Vet Clin North Am Small Anim Pract,2008, 38(4):879-901, ix. DOI:10. 1016/j.cvsm. 2008. 03. 005.
[2] Jarrett WFH, Crawford EM, Martin WB, et al.Leuk?mia in the cat:a virus-like particle associated with leuk?mia(lymphosarcoma)[J]. Nature, 1964, 202:567-568. DOI:10. 1038/202567a0.
[3] Collado VM, Domenech A, MiróG, et al.Epidemiological aspects and clinicopathological findings in cats naturally infected with feline leukemia virus(FeLV)and/or feline immunodeficiency virus(FIV)[J]. Open J Vet Med, 2012, 2(1):13-20. DOI:10. 4236/ojvm. 2012. 21003.
[4] Sykes JE, Hartmann K. Feline leukemia virus infection[M]//Canine and Feline Infectious Diseases.Amsterdam:Elsevier, 2014:224-238. DOI:10. 1016/b978-1-4377-0795-3. 00022-3.
[5] Willett BJ, Hosie MJ. Feline leukemia and sarcoma viruses(Retroviridae)[M]//Encyclopedia of Virology.Amsterdam:Elsevier, 2021:300-305. DOI:10. 1016/b978-0-12-814515-9. 00043-6.
[6] Chiu ES, Hoover EA, VandeWoude S. A retrospective examination of feline leukemia subgroup characterization:viral interference assays to deep sequencing[J]. Viruses, 2018, 10(1):29. DOI:10. 3390/v10010029.
[7] Ortiz R, Barajas A, Pons-Grífols A, et al. Exploring FeLV-gag-based VLPs as a new vaccine platformanalysis of production and immunogenicity[J]. Int J Mol Sci, 2023, 24(10):9025. DOI:10. 3390/ijms24109025.
[8] Elder JH, McGee JS, Munson M, et al. Localization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies[J]. J Virol, 1987, 61(1):8-15. DOI:10. 1128/JVI. 61. 1. 8-15. 1987.
[9] Polani S, Roca AL, Rosensteel BB, et al. Evolutionary dynamics of endogenous feline leukemia virus proliferation among species of the domestic cat lineage[J]. Virology, 2010, 405(2):397-407. DOI:10. 1016/j. virol. 2010. 06. 010.
[10]Cano-Ortiz L, Tochetto C, Roehe PM, et al. Could phylogenetic analysis be used for feline leukemia virus(FeLV)classification?[J]. Viruses, 2022, 14(2):249. DOI:10. 3390/v14020249.
[11]Tandon R, Cattori V, Willi B, et al. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays[J]. Vet Immunol Immunopathol, 2008, 123(1-2):129-133. DOI:10. 1016/j. vetimm. 2008. 01. 027.
[12]Tandon R, Cattori V, Pepin AC, et al. Association between endogenous feline leukemia virus loads and exogenous feline leukemia virus infection in domestic cats[J]. Virus Res, 2008, 135(1):136-143. DOI:10. 1016/j. virusres. 2008. 02. 016.
[13]Powers JA, Chiu ES, Kraberger SJ, et al. Feline leukemia virus(FeLV)disease outcomes in a domestic cat breeding colony:relationship to endogenous FeLV and other chronic viral infections[J]. J Virol, 2018, 92(18):e00649-18. DOI:10. 1128/JVI. 00649-18.
[14]Benveniste RE, Sherr CJ, Todaro GJ. Evolution of type C viral genes:origin of feline leukemia virus[J].Science, 1975, 190(4217):886-888. DOI:10. 1126/science. 52892.
[15]Willett BJ, Hosie MJ. Feline leukaemia virus:half a century since its discovery[J]. Vet J, 2013, 195(1):16-23. DOI:10. 1016/j. tvjl. 2012. 07. 004.
[16]Sarma PS, Log T. Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests[J]. Virology, 1973, 54(1):160-169. DOI:10. 1016/0042-6822(73)90125-6.
[17]Miyake A, Watanabe S, Hiratsuka T, et al. Novel feline leukemia virus interference group based on the env gene[J]. J Virol, 2016, 90(9):4832-4837. DOI:10. 1128/JVI. 03229-15.
[18]Jarrett O, Hardy WD, Golder MC, et al. The frequency of occurrence of feline leukaemia virus subgroups in cats[J]. Int J Cancer, 1978, 21(3):334-337. DOI:10. 1002/ijc. 2910210314.
[19]Overbaugh J, Riedel N, Hoover EA, et al.Transduction of endogenous envelope genes by feline leukaemia virus in vitro[J]. Nature, 1988, 332(6166):731-734. DOI:10. 1038/332731a0.
[20]Stewart MA, Warnock M, Wheeler A, et al.Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses[J].J Virol, 1986, 58(3):825-834. DOI:10. 1128/JVI. 58. 3. 825-834. 1986.
[21]MacKey L, Jarrett W, Jarrett O, et al. Anemia associated with feline leukemia virus infection in cats[J]. J Natl Cancer Inst, 1975, 54(1):209-217. DOI:10. 1093/jnci/54. 1. 209.
[22]Anai Y, Ochi H, Watanabe S, et al. Infectious endogenous retroviruses in cats and emergence of recombinant viruses[J]. J Virol, 2012, 86(16):8634-8644. DOI:10. 1128/JVI. 00280-12.
[23]Donahue PR, Quackenbush SL, Gallo MV, et al. Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS[J]. J Virol, 1991, 65(8):4461-4469. DOI:10. 1128/JVI. 65. 8. 4461-4469. 1991.
[24]Mullins JI, Hoover EA, Overbaugh J, et al. FeLVFAIDS-induced immunodeficiency syndrome in cats[J].Vet Immunol Immunopathol, 1989, 21(1):25-37.DOI:10. 1016/0165-2427(89)90127-x.
[25]Mendoza R, Anderson MM, Overbaugh J. A putative thiamine transport protein is a receptor for feline leukemia virus subgroup A[J]. J Virol, 2006, 80(7):3378-3385. DOI:10. 1128/JVI. 80. 7. 3378-3385. 2006.
[26]Takeuchi Y, Vile RG, Simpson G, et al. Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus[J]. J Virol,1992, 66(2):1219-1222. DOI:10. 1128/JVI. 66. 2. 1219-1222. 1992.
[27]Anderson MM, Lauring AS, Robertson S, et al. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses[J]. J Virol, 2001, 75(22):10563-10572. DOI:10. 1128/JVI. 75. 22. 10563-10572. 2001.
[28]Boomer S, Eiden M, Burns CC, et al. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2receptor recognition[J]. J Virol, 1997, 71(11):8116-8123. DOI:10. 1128/JVI. 71. 11. 8116-8123. 1997.
[29]Tailor CS, Willett BJ, Kabat D. A putative cell surface receptor for Anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily[J].J Virol, 1999, 73(8):6500-6505. DOI:10. 1128/JVI. 73. 8. 6500-6505. 1999.
[30]Quigley JG, Burns CC, Anderson MM, et al. Cloning of the cellular receptor for feline leukemia virus subgroup C(FeLV-C), a retrovirus that induces red cell aplasia[J]. Blood, 2000, 95(3):1093-1099.
[31]Miyake A, Kawasaki J, Ngo H, et al. Reduced folate carrier:an entry receptor for a novel feline leukemia virus variant[J]. J Virol, 2019, 93(13):e00269-19.DOI:10. 1128/JVI. 00269-19.
[32]Anderson MM, Lauring AS, Burns CC, et al.Identification of a cellular cofactor required for infection by feline leukemia virus[J]. Science, 2000, 287(5459):1828-1830. DOI:10. 1126/science. 287. 5459. 1828.
[33]Gomes-Keller MA, G?nczi E, Grenacher B, et al.Fecal shedding of infectious feline leukemia virus and its nucleic acids:a transmission potential[J]. Vet Microbiol, 2009, 134(3-4):208-217. DOI:10. 1016/j. vetmic. 2008. 08. 011.
[34]Cattori V, Tandon R, Riond B, et al. The kinetics of feline leukaemia virus shedding in experimentally infected cats are associated with infection outcome[J].Vet Microbiol, 2009, 133(3):292-296. DOI:10. 1016/j. vetmic. 2008. 07. 001.
[35]Hardy WD, Hess PW, Essex M, et al. Horizontal transmission of feline leukemia virus in cats[J]. Bibl Haematol, 1975(40):67-74. DOI:10. 1159/000397519.
[36]Pacitti AM, Jarrett O, Hay D. Transmission of feline leukaemia virus in the milk of a non-viraemic cat[J].Vet Rec, 1986, 118(14):381-384. DOI:10. 1136/vr. 118. 14. 381.
[37]Vobis M, D’Haese J, Mehlhorn H, et al. Evidence of horizontal transmission of feline leukemia virus by the cat flea(Ctenocephalides felis)[J]. Parasitol Res, 2003, 91(6):467-470. DOI:10. 1007/s00436-003-0949-8.
[38]Hoover EA, Olsen RG, Hardy WD, et al. Feline leukemia virus infection:age-related variation in response of cats to experimental infection[J]. J Natl Cancer Inst, 1976, 57(2):365-369. DOI:10. 1093/jnci/57. 2. 365.
[39]Cong W, Meng QF, Blaga R, et al. Toxoplasma gondii, Dirofilaria immitis, feline immunodeficiency virus(FIV), and feline leukemia virus(FeLV)infections in stray and pet cats(Felis catus)in Northwest China:co-infections and risk factors[J].Parasitol Res, 2016, 115(1):217-223. DOI:10. 1007/s00436-015-4738-y.
[40]马丽莹，刘恩琪，黄舒萍，等.哈尔滨地区猫白血病病毒流行情况及遗传变异分析[J].黑龙江畜牧兽医，2022(10):86-89. DOI:10. 13881/j. cnki.hljxmsy. 2021. 04. 0347.
[41]郭梦帅. 2023年中国部分地区猫主要病毒病的流行病学调查及猫白血病病毒的遗传演化分析[D].泰安：山东农业大学，2024. DOI:10. 27277/d. cnki.gsdnu. 2024. 000333.
[42]Pandolfo GW, de Cristo TG, Withoeft JA, et al.Neoplastic and non-neoplastic diseases associated with feline leukaemia virus(FeLV)in cats in southern Brazil[J]. Comp Immunol Microbiol Infect Dis, 2024, 112:102228. DOI:10. 1016/j. cimid. 2024. 102228.
[43]Meli ML, Pineroli B, Geisser E, et al. Prospective investigation of feline leukemia virus infection in stray cats subjected to a trap-neuter-return program in Switzerland[J]. Viruses, 2024, 16(3):394. DOI:10. 3390/v16030394.
[44]Beatty JA, Choi YR, Nekouei O, et al. Epidemiology of pathogenic retroviruses and domestic cat hepadnavirus in community and client-owned cats in Hong Kong[J].Viruses, 2024, 16(2):167. DOI:10. 3390/v16020167.
[45]Giselbrecht J, J?hne S, Bergmann M, et al. Prevalence of different courses of feline leukaemia virus infection in four European countries[J]. Viruses, 2023, 15(8):1718. DOI:10. 3390/v15081718.
[46]Pare A, Ellis A, Juette T. Clinicopathological findings of FeLV-positive cats at a secondary referral center in Florida, USA(2008-2019)[J]. PLoS One, 2022, 17(4):e0266621. DOI:10. 1371/journal. pone. 0266621.
[47]Levy J, Crawford C, Hartmann K, et al. 2008American Association of Feline Practitioners'feline retrovirus management guidelines[J]. J Feline Med Surg, 2008, 10(3):300-316. DOI:10. 1016/j.jfms. 2008. 03. 002.
[48]Rojko JL, Hoover EA, Mathes LE, et al. Pathogenesis of experimental feline leukemia virus infection[J]. J Natl Cancer Inst, 1979, 63(3):759-768. DOI:10. 1093/jnci/63. 3. 759.
[49]Hartmann K. Clinical aspects of feline retroviruses:a review[J]. Viruses, 2012, 4(11):2684-2710. DOI:10. 3390/v4112684.
[50]Torres AN, Mathiason CK, Hoover EA. Reexamination of feline leukemia virus:host relationships using real-time PCR[J]. Virology, 2005, 332(1):272-283. DOI:10. 1016/j. virol. 2004. 10. 050.
[51]Major A, Cattori V, Boenzli E, et al. Exposure of cats to low doses of FeLV:seroconversion as the sole parameter of infection[J]. Vet Res, 2010, 41(2):17.DOI:10. 1051/vetres/2009065.
[52]Hayes KA, Rojko JL, Tarr MJ, et al. Atypical localised viral expression in a cat with feline leukaemia[J]. Vet Rec, 1989, 124(13):344-346. DOI:10. 1136/vr. 124. 13. 344.
[53]Hartmann K, Donath A, Beer B, et al. Use of two virustatica(AZT, PMEA)in the treatment of FIV and of FeLV seropositive cats with clinical symptoms[J].Vet Immunol Immunopathol, 1992, 35(1-2):167-175.DOI:10. 1016/0165-2427(92)90129-e.
[54]Nelson P, Sellon R, Novotney C, et al. Therapeutic effects of diethylcarbamazine and 3'-azido-3'-deoxythymidine on feline leukemia virus lymphoma formation[J]. Vet Immunol Immunopathol, 1995, 46(1-2):181-194. DOI:10. 1016/0165-2427(94)07017-2.
[55]Cattori V, Weibel B, Lutz H. Inhibition of Feline leukemia virus replication by the integrase inhibitor Raltegravir[J]. Vet Microbiol, 2011, 152(1-2):165-168. DOI:10. 1016/j. vetmic. 2011. 03. 039.
[56]Jirjis F F, Davis T, Lane J, et al. Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine[J]. Vet Ther, 2010, 11(2):E1-6.
[57]Grosenbaugh DA, Frances-Duvert V, Abedi S, et al.Efficacy of a nonadjuvanted recombinant FeLV vaccine and two inactivated FeLV vaccines when subject to consistent virulent FeLV challenge conditions[J].Biologicals, 2017, 49:76-80. DOI:10. 1016/j.biologicals. 2016. 10. 004.
[58]Kanellos T, Sutton DJ, Salisbury CF, et al. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens[J]. J Feline Med Surg, 2008, 10(4):346-354. DOI:10. 1016/j. jfms. 2008. 02. 001.
[59]Sparkes AH. Feline leukaemia virus and vaccination[J]. J Feline Med Surg, 2003, 5(2):97-100. DOI:10. 1016/S1098-612X(02)00132-8.
基本信息:
DOI：10.13242/j.cnki.bingduxuebao.004678
中图分类号:S852.65
引用信息:
[1]庞帅赛,朱世强,刘光清,等.猫白血病病毒的研究进展[J].病毒学报().DOI:10.13242/j.cnki.bingduxuebao.004678.
基金信息:
中国农业科学院上海兽医研究所科技创新工程
2025-01-21
2025-01-21
2025-01-21